Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Millennium Review
  • Published:

The promise of nucleic acid vaccines

Gene Therapy volume 7, pages 89–92 (2000)Cite this article

Abstract

Establishing the effective use of ‘naked’ nucleic acids as vaccines would undoubtedly be one of the most important advances in the history of vaccinology. While nucleic acids show much promise for use as vaccine vectors in experimental animals, not a single naked nucleic acid vector has been approved for use in humans. Indeed, data from human clinical trials is scant: nucleic acid vaccines have not been clearly demonstrated to have any convincing efficacy in the prevention or treatment of infectious disease or cancer. Here we illustrate possible mechanisms underlying effective nucleic acid vaccination. We focus on progress that has been made in the improvement of their function. Additionally, we identify promising new strategies and try to forecast future developments that could lead to the real success of nucleic acid vaccines in the prevention and treatment of human disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Tang DC, DeVit M, Johnston SA . Genetic immunization is a simple method for eliciting an immune response Nature 1992 356: 152–154

    Article  CAS  PubMed  Google Scholar 

  2. Ulmer JB et al. Heterologous protection against influenza by injection of DNA encoding a viral protein Science 1993 259: 1745–1749

    Article  CAS  PubMed  Google Scholar 

  3. Davis HL, Whalen RG, Demeneix BA . Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression Hum Gene Ther 1993 4: 151–159

    Article  PubMed  Google Scholar 

  4. Corr M et al. Gene vaccination with naked plasmid DNA: mechanism of CTL priming J Exp Med 1996 184: 1555–1560

    Article  CAS  PubMed  Google Scholar 

  5. Doe B et al. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells Proc Natl Acad Sci USA 1996 93: 8578–8583

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Iwasaki A et al. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization atdifferent sites J Immunol 1997 159: 11–14

    CAS  PubMed  Google Scholar 

  7. Bronte V et al. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine Proc Natl Acad Sci USA 1997 94: 3183–3188

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Condon C et al. DNA-based immunization by in vivo transfection of dendritic cells Nature Med 1996 2: 1122–1128

    Article  CAS  PubMed  Google Scholar 

  9. Porgador A et al. Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization J Exp Med 1998 188: 1075–1082

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Matzinger P . An innate sense of danger Semin Immunol 1998 10: 399–415

    Article  CAS  PubMed  Google Scholar 

  11. Leitner WW, Ying H, Restifo NP . Enhancement of tumor specific immune response with plasmid DNA replicon vectors Cancer Res 2000 (in press)

  12. Ying H et al. Cancer therapy using a self-replicating RNAvaccine Nature Med 1999 5: 823–827

    Article  CAS  PubMed  Google Scholar 

  13. Chen Y et al. DNA vaccines encoding full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors Cancer Res 1998 58: 1965–1971

    CAS  PubMed  Google Scholar 

  14. Minev BR et al. Insertion signal sequence fused to minimal peptides elicits specific CD8+ T cell responses and prolongs survival of thymoma-bearing mice Cancer Res 1994 54: 4155–4161

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Restifo NP et al. Antigen processing in vivo and the elicitation of primary CTL responses J Immunol 1995 154: 4414–4422

    CAS  PubMed  Google Scholar 

  16. Fu TM et al. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization J Virol 1997 71: 2715–2721

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Ciernik IF, Berzofsky JA, Carbone DP . Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes J Immunol 1996 156: 2369–2375

    CAS  PubMed  Google Scholar 

  18. Restifo NP . The new vaccines: building viruses that elicit antitumor immunity Curr Opin Immunol 1996 8: 658–663

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Irvine KR et al. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases J Immunol 1996 156: 238–245

    CAS  PubMed  Google Scholar 

  20. Bronte V et al. IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases J Immunol 1995 154: 5282–5292

    CAS  PubMed  Google Scholar 

  21. Xiang Z, Ertl HC . Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines Immunity 1995 2: 129–135

    Article  CAS  PubMed  Google Scholar 

  22. Conry RM et al. Selected strategies to augment polynucleotide immunization Gene Therapy 1996 3: 67–74

    CAS  PubMed  Google Scholar 

  23. Huang AY et al. Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo? J Exp Med 1996 183: 769–776

    Article  CAS  PubMed  Google Scholar 

  24. Biragyn A et al. Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity Nat Biotechnol 1999 17: 253–258

    Article  CAS  PubMed  Google Scholar 

  25. Ellis JR et al. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer Nature Med 1995 1: 464–470

    Article  CAS  PubMed  Google Scholar 

  26. Krieg AM . Lymphocyte activation by CpG dinucleotide motifs in prokaryotic DNA Trends Microbiol 1996 4: 73–76

    Article  CAS  PubMed  Google Scholar 

  27. Krieg AM et al. The role of CpG dinucleotides in DNA vaccines Trends Microbiol 1998 6: 23–27

    Article  CAS  PubMed  Google Scholar 

  28. Weiner GJ et al. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization Ppoc Natl Acad Sci USA 1997 94: 10833–10837

    Article  CAS  Google Scholar 

  29. Leitner WW, Ying H, Restifo NP . DNA and RNA-based vaccines: principles, progress and prospects Vaccine 1999 18: 765–777

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Yeung MC, Liu J, Lau AS . An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells Proc Natl Acad Sci USA 1996 93: 12451–12455

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Castelli JC et al. A study of the interferon antiviral mechanism: apoptosis activation by the 2–5A system J Exp Med 1997 186: 967–972

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Berglund P et al. Enhancing immune responses using suicidal DNA vaccines Nat Biotechnol 1998 16: 562–565

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgery Branch, National Cancer Institute, Bethesda, MD, USA

    N P Restifo, H Ying, L Hwang & W W Leitner

Authors
  1. N P Restifo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H Ying
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W W Leitner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Restifo, N., Ying, H., Hwang, L. et al. The promise of nucleic acid vaccines. Gene Ther 7, 89–92 (2000). https://doi.org/10.1038/sj.gt.3301117

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301117

Keywords

This article is cited by

Search

Advanced search

Quick links